FDA moves toward easing restrictions on certain peptides BioPharma Dive The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN Gray Market Peptides: So Much Hype, So Little Data The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law BPC 157: Experimental Peptide Creates Risk for Athletes